U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources. Shares of ...

HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...

Bullish option flow detected in Moderna (MRNA) with 76,253 calls trading, 1.4x expected, and implied vol increasing almost 8 points to 77.82%. Feb-25 35 calls and Feb-25 34 calls are the most ...

UBS lowered the firm’s price target on Moderna (MRNA) to $78 from $96 and keeps a Buy rating on the shares. UBS believes Moderna’s oncology franchise is underappreciated onto melanoma Phase 3 ...

Star Trek has been around for so long now that, for the purposes of a listicle like this, it seems only fair to group the franchise’s output by era. You’ve got The Original Series period of ...

Moderna’s CEO said the company is working on multiple new COVID booster shot candidates that are an attempt to offer better protection against coronavirus variants. More than 28.3 million ...